The veterinary stereotactic radiosurgery system market size has grown rapidly in recent years. It will grow from $3.28 billion in 2025 to $3.69 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to rising incidence of cancer in companion animals, advancements in veterinary oncology, growth of veterinary specialty hospitals, increasing availability of imaging technologies, demand for precision radiation therapy.
The veterinary stereotactic radiosurgery system market size is expected to see rapid growth in the next few years. It will grow to $5.9 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to development of high-precision radiation delivery systems, integration of AI in treatment planning, growth in canine and feline oncology programs, increasing investments in veterinary cancer care, expansion of contract research organizations (CROs) supporting animal oncology. Major trends in the forecast period include increasing adoption of stereotactic radiosurgery in veterinary oncology, development of minimally invasive treatment options, integration of advanced imaging for precise tumor targeting, expansion of specialized veterinary cancer centers, rising awareness of pet cancer treatment options.
The growing pet population is expected to drive the growth of the veterinary stereotactic radiosurgery system market going forward. Pet population refers to the total number of domesticated animals, such as dogs, cats, and other pets, that are kept and cared for by people within a specific area or community. The pet population is increasing as more households adopt animals for companionship, leading to a larger number of pets under care. Veterinary stereotactic radiosurgery systems support pet health by providing precise, non-invasive treatment for tumors and other serious conditions, improving recovery outcomes and overall quality of life. For example, in July 2025, according to the World Animal Foundation (WAF), a US-based animal welfare organization, pet ownership in the U.S. reached 71% of households, up from 66% in 2023-2024. Therefore, the rise in the pet population is fueling the growth of the veterinary stereotactic radiosurgery system market.
Leading companies operating in the veterinary stereotactic radiosurgery system market are focusing on technological advancements, such as AI-driven image-guided treatment delivery platforms, to strengthen their competitive position. AI-driven image-guided treatment delivery platforms are integrated digital systems that combine artificial intelligence with imaging and robotic controls to plan, prescribe, and accurately deliver stereotactic radiation therapies, improving treatment precision, reducing procedure times, and enhancing clinical workflow efficiency. For instance, in September 2024, BluePearl Veterinary Partners LLC, a US-based veterinary care provider, introduced the CyberKnife System for veterinary use, featuring a robotic linear accelerator capable of delivering high-energy photon beams from multiple angles, real-time imaging guidance to minimize exposure to healthy tissue, and sub-millimeter targeting precision for complex tumors. This technology expands access to advanced oncology care for animals and strengthens specialty clinical capabilities, though it requires significant investment in training and infrastructure.
In November 2025, Empyrean Medical Systems Inc., a US-based medical technology company, formed a strategic partnership with Pathway Vet Alliance LLC to deploy its Sirius advanced radiation platform and broaden access to precision stereotactic radiation therapy for pets. Through this collaboration, Empyrean aims to introduce its Sirius platform into the veterinary oncology market, providing human-grade precision stereotactic radiation therapy for pets battling cancer. Pathway Vet Alliance LLC is a US-based veterinary services network that offers access to the Veterinary Stereotactic Radiosurgery (SRS) system.
Major companies operating in the veterinary stereotactic radiosurgery system market are PetCure Oncology, Elekta AB, Accuray Incorporated, Varian Medical Systems Inc., ZAP Surgical Systems Inc., Brainlab AG, Best Medical International Inc., Mevion Medical Systems Inc., Vision RT Limited, ViewRay Inc., Xstrahl Ltd., Avante Health Solutions, Medtronic plc, RaySearch Laboratories, Best Theratronics Ltd., MASEP Medical Science Technology Development Co Ltd, RefleXion Medical Inc., CIVCO Radiotherapy, Xcision Medical Systems, GammaVet, RadVet, ALCEN, Isoray Inc., PTW Freiburg GmbH, Ion Beam Applications SA, Nanovi Radiotherapy AS.
North America was the largest region in the veterinary stereotactic radiosurgery system market in 2025. The regions covered in the veterinary stereotactic radiosurgery system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary stereotactic radiosurgery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the veterinary stereotactic radiosurgery system market by increasing costs of imported microsurgical instruments, imaging systems, and radiation delivery equipment, affecting hospital and CRO budgets. Companion animal oncology segments in North America and Europe are most affected due to dependence on high-precision imported devices. Positively, tariffs are encouraging local manufacturing, innovation in cost-effective treatment systems, and adoption of domestic alternatives, helping strengthen regional supply chains and reduce long-term dependency on imports.
The veterinary stereotactic radiosurgery system market research report is one of a series of new reports that provides veterinary stereotactic radiosurgery system market statistics, including veterinary stereotactic radiosurgery system industry global market size, regional shares, competitors with a veterinary stereotactic radiosurgery system market share, detailed veterinary stereotactic radiosurgery system market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary stereotactic radiosurgery system industry. This veterinary stereotactic radiosurgery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A veterinary stereotactic radiosurgery system is a form of external radiation therapy that precisely positions the patient while delivering a single, high dosage of radiation to a tumor.
The primary types of veterinary stereotactic radiosurgery systems encompass microsurgical instrumentation, optical or viewing instruments, and other related products. Microsurgical instrumentation refers to hand-held surgical tools designed specifically for microsurgical and delicate procedures, facilitating the handling of fragile tissues, tendons, and blood vessels. Various modalities involved in these systems include gamma knife, linear accelerator, particle beam radiation therapy, and cyber knife, which are utilized for applications in canine, feline, and other veterinary scenarios. Different end users for these systems include hospitals, contract research organizations (CROs), and other relevant entities.
A veterinary stereotactic radiosurgery system market includes revenues earned by entities by veterinary stereotactic radiosurgery system that are used in the treatment of cancers and other issues that affect the brain, neck, lungs, liver, spine, and other areas of the body of pets and animals. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The veterinary stereotactic radiosurgery system market size is expected to see rapid growth in the next few years. It will grow to $5.9 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to development of high-precision radiation delivery systems, integration of AI in treatment planning, growth in canine and feline oncology programs, increasing investments in veterinary cancer care, expansion of contract research organizations (CROs) supporting animal oncology. Major trends in the forecast period include increasing adoption of stereotactic radiosurgery in veterinary oncology, development of minimally invasive treatment options, integration of advanced imaging for precise tumor targeting, expansion of specialized veterinary cancer centers, rising awareness of pet cancer treatment options.
The growing pet population is expected to drive the growth of the veterinary stereotactic radiosurgery system market going forward. Pet population refers to the total number of domesticated animals, such as dogs, cats, and other pets, that are kept and cared for by people within a specific area or community. The pet population is increasing as more households adopt animals for companionship, leading to a larger number of pets under care. Veterinary stereotactic radiosurgery systems support pet health by providing precise, non-invasive treatment for tumors and other serious conditions, improving recovery outcomes and overall quality of life. For example, in July 2025, according to the World Animal Foundation (WAF), a US-based animal welfare organization, pet ownership in the U.S. reached 71% of households, up from 66% in 2023-2024. Therefore, the rise in the pet population is fueling the growth of the veterinary stereotactic radiosurgery system market.
Leading companies operating in the veterinary stereotactic radiosurgery system market are focusing on technological advancements, such as AI-driven image-guided treatment delivery platforms, to strengthen their competitive position. AI-driven image-guided treatment delivery platforms are integrated digital systems that combine artificial intelligence with imaging and robotic controls to plan, prescribe, and accurately deliver stereotactic radiation therapies, improving treatment precision, reducing procedure times, and enhancing clinical workflow efficiency. For instance, in September 2024, BluePearl Veterinary Partners LLC, a US-based veterinary care provider, introduced the CyberKnife System for veterinary use, featuring a robotic linear accelerator capable of delivering high-energy photon beams from multiple angles, real-time imaging guidance to minimize exposure to healthy tissue, and sub-millimeter targeting precision for complex tumors. This technology expands access to advanced oncology care for animals and strengthens specialty clinical capabilities, though it requires significant investment in training and infrastructure.
In November 2025, Empyrean Medical Systems Inc., a US-based medical technology company, formed a strategic partnership with Pathway Vet Alliance LLC to deploy its Sirius advanced radiation platform and broaden access to precision stereotactic radiation therapy for pets. Through this collaboration, Empyrean aims to introduce its Sirius platform into the veterinary oncology market, providing human-grade precision stereotactic radiation therapy for pets battling cancer. Pathway Vet Alliance LLC is a US-based veterinary services network that offers access to the Veterinary Stereotactic Radiosurgery (SRS) system.
Major companies operating in the veterinary stereotactic radiosurgery system market are PetCure Oncology, Elekta AB, Accuray Incorporated, Varian Medical Systems Inc., ZAP Surgical Systems Inc., Brainlab AG, Best Medical International Inc., Mevion Medical Systems Inc., Vision RT Limited, ViewRay Inc., Xstrahl Ltd., Avante Health Solutions, Medtronic plc, RaySearch Laboratories, Best Theratronics Ltd., MASEP Medical Science Technology Development Co Ltd, RefleXion Medical Inc., CIVCO Radiotherapy, Xcision Medical Systems, GammaVet, RadVet, ALCEN, Isoray Inc., PTW Freiburg GmbH, Ion Beam Applications SA, Nanovi Radiotherapy AS.
North America was the largest region in the veterinary stereotactic radiosurgery system market in 2025. The regions covered in the veterinary stereotactic radiosurgery system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary stereotactic radiosurgery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the veterinary stereotactic radiosurgery system market by increasing costs of imported microsurgical instruments, imaging systems, and radiation delivery equipment, affecting hospital and CRO budgets. Companion animal oncology segments in North America and Europe are most affected due to dependence on high-precision imported devices. Positively, tariffs are encouraging local manufacturing, innovation in cost-effective treatment systems, and adoption of domestic alternatives, helping strengthen regional supply chains and reduce long-term dependency on imports.
The veterinary stereotactic radiosurgery system market research report is one of a series of new reports that provides veterinary stereotactic radiosurgery system market statistics, including veterinary stereotactic radiosurgery system industry global market size, regional shares, competitors with a veterinary stereotactic radiosurgery system market share, detailed veterinary stereotactic radiosurgery system market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary stereotactic radiosurgery system industry. This veterinary stereotactic radiosurgery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A veterinary stereotactic radiosurgery system is a form of external radiation therapy that precisely positions the patient while delivering a single, high dosage of radiation to a tumor.
The primary types of veterinary stereotactic radiosurgery systems encompass microsurgical instrumentation, optical or viewing instruments, and other related products. Microsurgical instrumentation refers to hand-held surgical tools designed specifically for microsurgical and delicate procedures, facilitating the handling of fragile tissues, tendons, and blood vessels. Various modalities involved in these systems include gamma knife, linear accelerator, particle beam radiation therapy, and cyber knife, which are utilized for applications in canine, feline, and other veterinary scenarios. Different end users for these systems include hospitals, contract research organizations (CROs), and other relevant entities.
A veterinary stereotactic radiosurgery system market includes revenues earned by entities by veterinary stereotactic radiosurgery system that are used in the treatment of cancers and other issues that affect the brain, neck, lungs, liver, spine, and other areas of the body of pets and animals. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Veterinary Stereotactic Radiosurgery System Market Characteristics
3. Veterinary Stereotactic Radiosurgery System Market Supply Chain Analysis
4. Global Veterinary Stereotactic Radiosurgery System Market Trends and Strategies
5. Veterinary Stereotactic Radiosurgery System Market Analysis of End Use Industries
7. Global Veterinary Stereotactic Radiosurgery System Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Veterinary Stereotactic Radiosurgery System Total Addressable Market (TAM) Analysis for the Market
9. Veterinary Stereotactic Radiosurgery System Market Segmentation
10. Veterinary Stereotactic Radiosurgery System Market Regional and Country Analysis
11. Asia-Pacific Veterinary Stereotactic Radiosurgery System Market
12. China Veterinary Stereotactic Radiosurgery System Market
13. India Veterinary Stereotactic Radiosurgery System Market
14. Japan Veterinary Stereotactic Radiosurgery System Market
15. Australia Veterinary Stereotactic Radiosurgery System Market
16. Indonesia Veterinary Stereotactic Radiosurgery System Market
17. South Korea Veterinary Stereotactic Radiosurgery System Market
18. Taiwan Veterinary Stereotactic Radiosurgery System Market
19. South East Asia Veterinary Stereotactic Radiosurgery System Market
20. Western Europe Veterinary Stereotactic Radiosurgery System Market
21. UK Veterinary Stereotactic Radiosurgery System Market
22. Germany Veterinary Stereotactic Radiosurgery System Market
23. France Veterinary Stereotactic Radiosurgery System Market
24. Italy Veterinary Stereotactic Radiosurgery System Market
25. Spain Veterinary Stereotactic Radiosurgery System Market
26. Eastern Europe Veterinary Stereotactic Radiosurgery System Market
27. Russia Veterinary Stereotactic Radiosurgery System Market
28. North America Veterinary Stereotactic Radiosurgery System Market
29. USA Veterinary Stereotactic Radiosurgery System Market
30. Canada Veterinary Stereotactic Radiosurgery System Market
31. South America Veterinary Stereotactic Radiosurgery System Market
32. Brazil Veterinary Stereotactic Radiosurgery System Market
33. Middle East Veterinary Stereotactic Radiosurgery System Market
34. Africa Veterinary Stereotactic Radiosurgery System Market
36. Veterinary Stereotactic Radiosurgery System Market Competitive Landscape and Company Profiles
37. Veterinary Stereotactic Radiosurgery System Market Other Major and Innovative Companies
40. Veterinary Stereotactic Radiosurgery System Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Veterinary Stereotactic Radiosurgery System Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses veterinary stereotactic radiosurgery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for veterinary stereotactic radiosurgery system? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary stereotactic radiosurgery system market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Microsurgical Instrumentation; Imaging And Visualization Systems; Radiation Therapy Systems And Software2) By Modality: Gamma Knife; Linear Accelerator; Particle Beam Radiation Therapy; Cyber Knife
3) By Application: Canine; Feline; Other Applications
4) By End User: Hospitals; Contract Research Organizations (CROs); Other End Users
Subsegments:
1) By Microsurgical Instrumentation: Stereotactic Frames; Navigation Systems; Targeting Devices2) By Imaging And Visualization Systems: Imaging Systems; Surgical Microscopes
3) By Radiation Therapy Systems And Software: Treatment Planning Software; Radiation Delivery Systems; Positioning Accessories Or Immobilization Devices
Companies Mentioned: PetCure Oncology; Elekta AB; Accuray Incorporated; Varian Medical Systems Inc.; ZAP Surgical Systems Inc.; Brainlab AG; Best Medical International Inc.; Mevion Medical Systems Inc.; Vision RT Limited; ViewRay Inc.; Xstrahl Ltd.; Avante Health Solutions; Medtronic plc; RaySearch Laboratories; Best Theratronics Ltd.; MASEP Medical Science Technology Development Co Ltd; RefleXion Medical Inc.; CIVCO Radiotherapy; Xcision Medical Systems; GammaVet; RadVet; ALCEN; Isoray Inc.; PTW Freiburg GmbH; Ion Beam Applications SA; Nanovi Radiotherapy AS
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Veterinary Stereotactic Radiosurgery System market report include:- PetCure Oncology
- Elekta AB
- Accuray Incorporated
- Varian Medical Systems Inc.
- ZAP Surgical Systems Inc.
- Brainlab AG
- Best Medical International Inc.
- Mevion Medical Systems Inc.
- Vision RT Limited
- ViewRay Inc.
- Xstrahl Ltd.
- Avante Health Solutions
- Medtronic plc
- RaySearch Laboratories
- Best Theratronics Ltd.
- MASEP Medical Science Technology Development Co Ltd
- RefleXion Medical Inc.
- CIVCO Radiotherapy
- Xcision Medical Systems
- GammaVet
- RadVet
- ALCEN
- Isoray Inc.
- PTW Freiburg GmbH
- Ion Beam Applications SA
- Nanovi Radiotherapy AS
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.69 Billion |
| Forecasted Market Value ( USD | $ 5.9 Billion |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
